Black Friday saleUp to 70% OFF
BIONTECH SEBIONTECH SEBIONTECH SE

BIONTECH SE

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals

22UA trade ideas

BNTX is facing an armed angry bear !Angry bear has mad a weapon integrating three powerful and heavy elements and waiting for the stock to hammer it down ! Long term down trend line , 200 days moving average and lost golden ratio Retracement level are the elements of the bear's weapon. Can BNTX make a heroic attack and defeat the angry bear? Not without a powerful comparable weapon I think. It needs a brilliant earning report or next wave of Covid or more positive sentiment in all market to survive facing such a frightening enemy. Anyways, I am excited to watch this up coming battle ! Who wins? Lest follow and watch closely.
NASDAQ:BNTX
by SaeedSajedi
BioNTech showing a solid entryBNTX is finally concluding a year long descending triangle pattern. I see a low risk entry at $150 and will be buying. Stop loss set at $138.49, risking about 8.5%. If we see a large move upward, I could see the stock retesting both its 200 day moving average (likely at $183) and its next major resistance after that at $295. A potential of nearly 100% profit (not to say its a sure bet or smart to dump huge amounts into the trade without the stop loss...). Fundamentally, the company has a P/E of 3, no debt, and a huge free cash flow to fund its mrna platforms for a lot of other diseases partnering with some of the largest pharma companies in the world. Yet another variant of covid, upward pressure from the 50and100 day MAs, large portions of the world unvaccinated, and president biden contracting the virus could be potential catalysts for a move. If you're looking for a bio tech exposure this is a stock that seems to be set up well. Good luck to all.
NASDAQ:BNTXLong
by Avatar_Trading
1
BionTech - Financial Health ExcellentThe Statistics say between $182-$253 (1 year) This Looks like it can Happen in 1 Year. That will depend on their Progress. Let's see what will happen in 2023, but it looks ok to hold for the next 5 Years or more BioNTech aims to develop the first mRNA-based vaccine for Malaria prevention with the initiation of a clinical trial by end of 2022 BioNTech is evaluating sustainable mRNA vaccine production capacities in Africa; the Company’s efforts are supported by the joint convening powers of the World Health Organization (WHO) and the Africa Centers for Disease Control and Prevention (Africa CDC) BioNTech’s Malaria project is part of the ‘eradicate malaria’ initiative, led by the kENUP Foundation, to accelerate the eradication of Malaria Disclaimer: Just my Idea! Find your Trading Ideas and learn and study more!
NASDAQ:BNTXLong
by TraderMentorX
Free Fallinnnnn $bntx has NO volume support until green box 24% lower... #bntx —————————————————————————————— Top 10 trading tips: 1. DO NOT FOMO into a trade. Let it come to you. Don’t force it. 2. Find a strategy that works for you and be consistent. Operate like a machine and less like the wind. 3. Let your winners run and cut your losers short. 4. You will not win every trade, but if you are disciplined with great RM you don't need to be right all the time to win! 5. Before you enter a trade, know your target AND your exit strategy. 6. When you are up, you can use a trailing stop or trim off some profit at a logical resistance point with a stop loss at breakeven. 7. Set your trade parameters up front so you keep your self accountable and remove emotions from the equation. (stop loss, take profit levels, etc) 8. Don't fight the trend. The trend is your friend. 9. Don’t enter a trade based on one indicator. 10. Horizontals > Diagonals Please note: - This is not financial advice. - I do not take every trade I post. - Never trade off of someone else's chart until you DYOR!
NASDAQ:BNTXShort
by DaCryptologist
1
BioNTech earnings 3/30 pre-marketBioNTech Q4 December 21' earnings are on 3/30 pre-market 6:45am. BioNTech Se ADR (BNTX) reported Q3 September 2021 earnings of $14.56 per share on revenue of $7.2 billion. The consensus earnings estimate was $11.79 per share on revenue of $5.8 billion. Revenue grew 9,003.0% on a year-over-year basis. I'm long now because a P/E = 3.7 for a leading MRNA biotechnology company heading into earnings is a rare opportunity. Plus, I waited until today from the technical entry I planned on Friday. Here's levels on the 1-day chart: Q4 December 21' Consensus: P/E = 3.7 EPS = $8.45 Revenue = $4.48B 52 week high = $464 52 week low = $93 SMA200 = $217 SMA100 =$206 breakout = $179 R3 = $169 R2 = $159 R1 = $150 pivot = $140 S1 = $130 S2 = $120 S3 = $111 breakdown = $101 Do your own due diligence, your risk is 100% your responsibility. This is for educational and entertainment purposes only. You win some or you learn some. Consider being charitable with some of your profit to help humankind. Good luck and happy trading friends... *3x lucky 7s of trading* 7pt Trading compass: Price action, entry/exit Volume average/direction Trend, patterns, momentum Newsworthy current events Revenue Earnings Balance sheet 7 Common mistakes: +5% portfolio trades, capital risk management Beware of analyst's motives Emotions & Opinions FOMO : bad timing, the market is ruthless, be shrewd Lack of planning & discipline Forgetting restraint Obdurate repetitive errors, no adaptation 7 Important tools: Trading View app!, Brokerage UI Accurate indicators & settings Wide screen monitor/s Trading log (pencil & graph paper) Big, organized desk Reading books, playing chess Sorted watch-list Checkout my indicators: Fibonacci VIP - volume Fibonacci MA7 - price pi RSI - trend momentum TTC - trend channel AlertiT - notification tickerTracker - MFI Oscillator www.tradingview.com
NASDAQ:BNTXLong
by Options360
2
BNTX HIGH RISK TO REWARD SETUP YOU CAN'T MISSNews - Better than expected Q4 EPS and sales results, the company expects to authorize a shares repurchase program up to 1.5B over the next two years. Levels -$195 is the next major resistance level. $138 is the next major support level. The stock is gapping up to $183 (pre-market). The idea is to go long at the open when it will try to test the $183 support level and fail, then go long above the 5M bull flag pattern if it will happen.
NASDAQ:BNTXLong
by TradeThePool
BNTX LONG SETUPWe just finished Elliot wave 1-5 and ABC pattern, already bounced off of a strong demand zone and 71.8% fib zone we can enter right now but our R/R ratio is 1.7 since we missed first bounce, what we are looking for is a retrace to our entry point ant 71.8% fib zone and enter there. Also market made a gap at 182 zone which has to be filled. Also a gap at 325 zone, which also needs to be filled. AROON: On a daily chart AROON already shows bullish momentum (Orange line above blue one) Bollinger band: we already bounced off of a bottom Bollinger band which indicates bullish direction movement. Entry:119 (We can enter right now but for better R/R I would suggest to wait for a retest at the entry zone, though it might not do that and we might miss a trade) Invalidation: 79 ( Just below Demand zone ) Target 1: 292 (50% FIB ZONE) Target 2: 325 (Second gap zone) Ratio if we wait for retest: 4.38 Ratio if we enter right now: 1.75
NASDAQ:BNTXLong
by vf_investment
1